RE: New proactive interview with Per6 Sep 2018 10:15
Just catching up with all the news after a few days offline.
Excellent RNS deal concerning our mystery USA pharma developer. Clearly the biggest potential deal to date.
The strange thing is this one deal will probably put our company in the black, and could easily make this stock a multibagger from here when the royalties flood in, due to the size of the markets available.
But this is just one deal, and opti have other deals and other strains and products with those have multiple deals.
By far my best stock, with the highest reward to risk ratio. Very happy to hold,